Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults
Clinical trial NCT00297687 · COMPLETED
Trial details
- NCT number
- NCT00297687
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.